ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Pancreatic Enzymes 11x

Also known as: Pancreatic Enzymes 11x, Pancreatic enzyme replacement therapy, PERT, pancreatic extracts, lipase, amylase, protease, trypsin, chymotrypsin, Pancreatin

Overview

Pancreatic enzymes, commonly known as pancreatin, are a mixture of digestive enzymes including lipase, amylase, and proteases (e.g., trypsin, chymotrypsin). The '11x' designation often refers to a specific potency or strength of the preparation. These enzymes are naturally produced by the exocrine pancreas to facilitate the digestion of fats, carbohydrates, and proteins. Supplement formulations are typically derived from porcine pancreas extracts and are standardized to specific enzyme activity levels. Pancreatic enzyme supplements are primarily used to treat exocrine pancreatic insufficiency (EPI), a condition where the pancreas does not produce enough enzymes to properly digest food. EPI can result from conditions such as chronic pancreatitis, cystic fibrosis, or pancreatic surgery. The supplements are often enteric-coated to protect the enzymes from degradation by stomach acid, ensuring their delivery and activity in the small intestine. The efficacy and safety of pancreatic enzyme replacement therapy (PERT) are well-supported by high-quality evidence from numerous randomized controlled trials and meta-analyses.

Benefits

Pancreatic enzyme replacement therapy (PERT) offers significant benefits primarily for individuals with exocrine pancreatic insufficiency (EPI). The most prominent benefit is a substantial improvement in fat absorption, as measured by the coefficient of fat absorption (CFA), and a reduction in steatorrhea (fatty stools). For instance, studies have shown that enzyme therapy can increase CFA from approximately 54% to 81% in patients with EPI. This leads to improved nutrient absorption and can alleviate symptoms associated with maldigestion. While the primary effect is on fat digestion, PERT also aids in the digestion of carbohydrates and proteins. Patients with chronic pancreatitis, those who have undergone pancreatic surgery, or individuals with cystic fibrosis are the populations that benefit most from PERT. Although some patients report trends toward improvement in abdominal symptoms like pain, distention, and flatulence, meta-analyses have not consistently shown a statistically significant effect on abdominal pain relief in chronic pancreatitis. The benefits are typically observed within weeks of initiating therapy, and high-quality evidence from systematic reviews and meta-analyses consistently supports the efficacy of PERT in improving nutritional parameters.

How it works

Pancreatic enzymes function by replacing the deficient endogenous enzymes in individuals with exocrine pancreatic insufficiency (EPI). Once ingested, the supplemented enzymes, primarily lipase, amylase, and proteases, are released in the small intestine. Lipase breaks down dietary fats into fatty acids and monoglycerides, amylase hydrolyzes carbohydrates into simpler sugars, and proteases break down proteins into peptides and amino acids. This enzymatic action facilitates the hydrolysis of macronutrients, making them available for absorption across the intestinal wall. The supplements act locally within the gastrointestinal tract, with minimal systemic absorption. Enteric-coated formulations are crucial as they protect the enzymes from inactivation by gastric acid in the stomach, ensuring their delivery to the duodenum where they can effectively catalyze the breakdown of food.

Side effects

Pancreatic enzyme supplements are generally considered safe and well-tolerated. The most common side effects, occurring in over 5% of users, are mild to moderate gastrointestinal symptoms such as abdominal pain, flatulence, and diarrhea. These symptoms are often related to the underlying exocrine pancreatic insufficiency rather than the enzyme therapy itself. Uncommon side effects, reported in 1-5% of cases, include rare disturbances in glucose control, particularly in insulin-dependent diabetics, necessitating careful monitoring of blood sugar levels. Serious adverse events are rare and have not been consistently linked to pancreatic enzyme replacement therapy. There are no major reported drug interactions with pancreatic enzymes. Contraindications include hypersensitivity to porcine proteins or any other components of the enzyme preparation. Caution is advised for insulin-dependent diabetics due to the potential for glucose metabolism effects. Overall, the safety profile is favorable, with most adverse effects being mild and manageable.

Dosage

The optimal dosage of pancreatic enzymes varies depending on the individual's degree of exocrine pancreatic insufficiency and the fat content of their meals. Dosing is typically titrated based on symptom control and improvement in fat absorption. Standard pancreatic enzyme replacement therapy (PERT) doses generally range from 25,000 to 80,000 USP lipase units per meal. For example, some studies have used lipase 40,000 USP units per meal. The enzymes should always be taken with meals and snacks to coincide with the passage of food through the digestive tract. Enteric-coated microspheres or mini-microspheres are the preferred formulations as they protect the enzymes from stomach acid, ensuring their delivery to the small intestine. While there is no strict maximum safe dose, high doses are generally well tolerated. In some cases, acid suppression therapy, such as proton pump inhibitors, may be used concurrently to enhance enzyme efficacy by further protecting them from gastric acid. No specific cofactors are required for their action.

FAQs

Is PERT effective for abdominal pain in chronic pancreatitis?

A meta-analysis indicates that pancreatic enzyme replacement therapy (PERT) does not provide significant relief for abdominal pain in chronic pancreatitis, despite improving digestion.

Can PERT disturb blood sugar control?

Rare cases of disturbed glucose control have been reported in insulin-dependent diabetics using PERT. Monitoring blood sugar levels is advised for these individuals.

How quickly does PERT work?

Improvements in fat absorption and reduction in symptoms like steatorrhea are typically observed within days to a few weeks of initiating pancreatic enzyme therapy.

Is PERT safe long-term?

Yes, pancreatic enzyme replacement therapy is generally considered safe for long-term use. Most reported side effects are mild and often related to the underlying digestive condition.

Research Sources

  • https://www.oncotarget.com/article/21659/text/ – This meta-analysis of 7 randomized controlled trials (n=282) found that pancreatic enzyme replacement therapy (PERT) significantly improved fat absorption and nutritional parameters in patients with chronic pancreatitis or post-pancreatic surgery compared to placebo. It also noted no significant difference in adverse events and no benefit for pain relief, highlighting PERT's efficacy for maldigestion but not pain.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC3462488/ – This randomized controlled trial involving 29 chronic pancreatitis patients with severe exocrine pancreatic insufficiency demonstrated that PERT increased the coefficient of fat absorption from 54% to 81% (p=0.002) and reduced fecal fat and nitrogen excretion. While it showed clear digestive benefits, it found no significant symptom differences and noted potential glucose control issues in diabetic patients.
  • https://www.wjgnet.com/2308-3840/full/v3/i6/254.htm – This systematic review and meta-analysis, while primarily focused on GLP-1 agents, indirectly supports the safety profile of pancreatic enzymes by concluding no increased risk of pancreatitis or pancreatic cancer with GLP-1 agents. Although not directly focused on PERT, it contributes to the broader understanding of pancreatic health and safety.

Recommended Articles

Diabetes & Supplements: What to Take or Avoid

Diabetes & Supplements: What to Take or Avoid

Certain supplements can benefit or harm individuals with type 2 diabetes, and interactions with medications are crucial to consider.